Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
modelling and computational neuroscience to human mobility behaviour; Modelling how people build and update internal representations of urban space; Integrating behavioural data with neurophysiological
-
research towards better cardiometabolic health. Through collaborative interdisciplinary research from single-cell genomics to whole-body systems, CBMR aims to transform the basic understanding
-
pharmaceutical data science Knowledge of cell biology, protein structures, and evolution Strong written and spoken English and good communication and collaboration skills The person will be required to relocate
-
@sund.ku.dk , mobile: +45 55236319. Start: 1 January 2027 (or after agreement) Duration: 3 years as a PhD student Job description Your key tasks as a PhD student at SUND are: Carrying
-
Neoplasms’ together with Professor George Vassiliou, Cambridge Stem Cell Institute, University of Cambridge, United Kingdom funded by a ‘Molecular Mechanisms Linking Obesity and Cancer (MMLOC)’ grant from
-
will receive: (i) a competitive living allowance (salary), a mobility allowance and a family allowance (if qualified); (ii) two funded 3-month secondments in the industry in TDC NET (Denmark) and Dell
-
PhD position in detector development for the next generation of cryogenic dark-matter axion exper...
doctoral program at CERN, and will have access to experimental facilities at both institutions. The position includes a mobility component of up to two years at CERN, undertaken within CERN's Technology
-
required to meet the European Commission’s MSCA Doctoral Network eligibility criteria, notably: Mobility Rule - Applicants can be of any nationality and must not have resided or carried out their main
-
mobile devices, impact both individual experiences and practices as well as collaboration within and across groups. How to apply Your application must include the following: Application, stating reasons
-
antigens targeting conserved B-cell and T-cell epitopes of respiratory pathogens. • Development of de novo protein scaffolds, nanoparticles, and multivalent immunogens. • Application of generative protein